134 related articles for article (PubMed ID: 37523582)
1. Lethal Respiratory Syncytial Virus in Zambia Is Sensitive to Long-acting Monoclonal Antibodies.
Langedijk AC; Vrancken B; Lebbink RJ; Evers A; Pieciak RC; Lemey P; Bont LJ; Gill CJ
Pediatr Infect Dis J; 2023 Nov; 42(11):e421-e423. PubMed ID: 37523582
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions.
Laufer RS; Driscoll AJ; Baral R; Buchwald AG; Campbell JD; Coulibaly F; Diallo F; Doumbia M; Galvani AP; Haidara FC; Kotloff KL; Keita AM; Neuzil KM; Orenstein EW; Orenstein LAV; Pecenka C; Sow S; Tapia MD; Ortiz JR; Fitzpatrick MC
Vaccine; 2021 Aug; 39(35):5037-5045. PubMed ID: 34325934
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus infection in children with acute respiratory infections in Zambia.
Saijo M; Terunuma H; Mizuta K; Mpabalwani EM; Monze M; Oshitani H; Luo N; Suzuki H; Numazaki Y
Epidemiol Infect; 1998 Oct; 121(2):397-400. PubMed ID: 9825792
[TBL] [Abstract][Full Text] [Related]
4. The use of humanized monoclonal antibodies for the prevention of respiratory syncytial virus infection.
Lanari M; Vandini S; Arcuri S; Galletti S; Faldella G
Clin Dev Immunol; 2013; 2013():359683. PubMed ID: 23840240
[TBL] [Abstract][Full Text] [Related]
5. Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections.
Weil-Olivier C; Salisbury D; Navarro-Alonso JA; Tzialla C; Zhang Y; Esposito S; Midulla F; Tenenbaum T
Hum Vaccin Immunother; 2023 Dec; 19(1):2209000. PubMed ID: 37193673
[TBL] [Abstract][Full Text] [Related]
6. Comparison of monoclonal antibody time-resolved fluoroimmunoassay with monoclonal antibody capture-biotinylated detector enzyme immunoassay for respiratory syncytial virus and parainfluenza virus antigen detection.
Hierholzer JC; Bingham PG; Coombs RA; Johansson KH; Anderson LJ; Halonen PE
J Clin Microbiol; 1989 Jun; 27(6):1243-9. PubMed ID: 2546973
[TBL] [Abstract][Full Text] [Related]
7. Infant deaths from respiratory syncytial virus in Lusaka, Zambia from the ZPRIME study: a 3-year, systematic, post-mortem surveillance project.
Gill CJ; Mwananyanda L; MacLeod WB; Kwenda G; Pieciak R; Mupila Z; Murphy C; Chikoti C; Forman L; Berklein F; Lapidot R; Chimoga C; Ngoma B; Larson A; Lungu J; Nakazwe R; Nzara D; Pemba L; Yankonde B; Chirwa A; Mwale M; Thea DM
Lancet Glob Health; 2022 Feb; 10(2):e269-e277. PubMed ID: 35063114
[TBL] [Abstract][Full Text] [Related]
8. WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.
Sparrow E; Adetifa I; Chaiyakunapruk N; Cherian T; Fell DB; Graham BS; Innis B; Kaslow DC; Karron RA; Nair H; Neuzil KM; Saha S; Smith PG; Srikantiah P; Were F; Zar HJ; Feikin D
Vaccine; 2022 Jun; 40(26):3506-3510. PubMed ID: 35184927
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens.
Nuñez Castrejon AM; O'Rourke SM; Kauvar LM; DuBois RM
J Virol; 2022 Apr; 96(7):e0220121. PubMed ID: 35266806
[TBL] [Abstract][Full Text] [Related]
10. Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies.
Lee Mortensen G; Harrod-Lui K
Expert Rev Vaccines; 2022 Oct; 21(10):1523-1531. PubMed ID: 35929971
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies against respiratory syncytial virus and their use for rapid detection of virus in nasopharyngeal secretions.
Pothier P; Nicolas JC; de Saint Maur GP; Ghim S; Kazmierczak A; Bricout F
J Clin Microbiol; 1985 Feb; 21(2):286-7. PubMed ID: 3882752
[TBL] [Abstract][Full Text] [Related]
12. The detection of respiratory syncytial virus in nasopharyngeal aspirates: assessment, formulation, and evaluation of monoclonal antibodies as a diagnostic reagent.
Freke A; Stott EJ; Roome AP; Caul EO
J Med Virol; 1986 Feb; 18(2):181-91. PubMed ID: 2419492
[TBL] [Abstract][Full Text] [Related]
13. Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies.
Palomo C; Albar JP; García-Barreno B; Melero JA
J Virol; 1990 Sep; 64(9):4199-206. PubMed ID: 2384917
[TBL] [Abstract][Full Text] [Related]
14. The clinical impact of multiple prevention strategies for respiratory syncytial virus infections in infants and high-risk toddlers in the United States.
Ektare V; Lang J; Choi Y; Finelli L
Vaccine; 2022 Oct; 40(42):6064-6073. PubMed ID: 36096968
[TBL] [Abstract][Full Text] [Related]
15. Bovine respiratory syncytial virus-specific monoclonal antibodies.
Klucas CA; Anderson GA
Vet Immunol Immunopathol; 1988 Jun; 18(4):307-15. PubMed ID: 3046116
[TBL] [Abstract][Full Text] [Related]
16. Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory Syncytial Virus Fusion Glycoprotein.
Beach SS; Hull MA; Ytreberg FM; Patel JS; Miura TA
J Virol; 2022 Jul; 96(13):e0035322. PubMed ID: 35678603
[TBL] [Abstract][Full Text] [Related]
17. Utility of a respiratory virus panel containing a monoclonal antibody pool for screening of respiratory specimens in nonpeak respiratory syncytial virus season.
McDonald JC; Quennec P
J Clin Microbiol; 1993 Oct; 31(10):2809-11. PubMed ID: 8253993
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
Djagbare MD; Yu L; Parupudi A; Sun J; Coughlin ML; Rush BS; Sanyal G
Vaccine; 2018 Mar; 36(12):1673-1680. PubMed ID: 29456016
[TBL] [Abstract][Full Text] [Related]
19. Current strategies and perspectives for active and passive immunization against Respiratory Syncytial Virus in childhood.
Scotta MC; Stein RT
J Pediatr (Rio J); 2023; 99 Suppl 1(Suppl 1):S4-S11. PubMed ID: 36402228
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection.
Welliver RC
Semin Perinatol; 1998 Feb; 22(1):87-95. PubMed ID: 9523402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
